Administration of Exogenous Melatonin After the Onset of Systemic Inflammation Is Hardly Beneficial
Crossref DOI link: https://doi.org/10.1007/s10753-017-0608-3
Published Online: 2017-06-15
Published Print: 2017-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brencher, Lisa
Oude Lansink, Maren
Effenberger-Neidnicht, Katharina
License valid from 2017-06-15